Table 3.
Risk factors for biliary candidiasis n (%)
| Risk factors | No biliary candidiasis (n = 89) | Biliary candidiasis (n = 38) | P value | Exp(B) | 95%CI for exp(B) |
| Age | 58.3 ± 15.6 | 64.7 ± 15.0 | 0.036 | 1.034 | 1.002-1.067 |
| Malignancy | 20 (22.5) | 15 (39.5) | 0.242 | 0.494 | 0.152-1.609 |
| Cholangio-carcinoma | 8 (9.0) | 7 (18.4) | 0.372 | 0.497 | 0.107-2.310 |
| Immunosup-pression | 42 (47.2) | 26 (68.4) | 0.058 | 0.403 | 0.158-1.031 |
| ICU | 2 (2.2) | 2 (5.3) | 1.000 | ||
| Mechanical ventilation | 2 (2.2) | 1 (2.6) | 1.000 | 2.3E+9 | |
| Antibiotic therapy | 42 (47.2) | 26 (68.4) | 0.200 | 0.530 | 0.201-1.399 |
| Long-term antibiotic therapy (> 7 d) | 9 (10.1) | 11 (28.9) | 0.089 | 0.354 | 0.107-1.170 |
| Previous EST | 51 (57.3) | 25 (65.8) | 0.012 | 0.246 | 0.082-0.739 |
| Previous ERCP | 53 (59.6) | 26 (68.4) | 0.574 | 1.318 | 0.504-3.444 |
ERCP: Endoscopic retrograde cholangiopancreatography; EST: Endoscopic sphincterotomy; ICU: Intensive care unit.